Gerald E. Hanks

Active 1964–2017

Also published as
Gerald E Hanks
104
Papers
19,362
Citations
86
h-index
104
i10-index

Citations

Citations per year for Gerald E. Hanks1931: 3 citations1953: 1 citations1966: 1 citations1970: 1 citations1972: 3 citations1973: 1 citations1976: 1 citations1977: 1 citations1979: 1 citations1983: 1 citations1984: 3 citations1985: 9 citations1986: 6 citations1987: 13 citations1988: 12 citations1989: 4 citations1990: 11 citations1991: 24 citations1992: 28 citations1993: 60 citations1994: 64 citations1995: 109 citations1996: 66 citations1997: 132 citations1998: 141 citations1999: 147 citations2000: 178 citations2001: 147 citations2002: 215 citations2003: 201 citations2004: 173 citations2005: 207 citations2006: 154 citations2007: 191 citations2008: 153 citations2009: 120 citations2010: 136 citations2011: 104 citations2012: 80 citations2013: 82 citations2014: 92 citations2015: 54 citations2016: 55 citations2017: 54 citations2018: 37 citations2019: 198 citations2020: 156 citations2021: 124 citations2022: 77 citations2023: 66 citations2024: 97 citations2025: 32 citations2026: 3 citations1932–1952: no citations, so these years are not shown1954–1965: no citations, so these years are not shown1967–1969: no citations, so these years are not shown1971: no citations, so this year is not shown1974–1975: no citations, so these years are not shown1978: no citations, so this year is not shown1980–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,563 citing papers, 39.3% of this breakdownCanada: 326 citing papers, 8.2% of this breakdownUnited Kingdom: 283 citing papers, 7.1% of this breakdownGermany: 183 citing papers, 4.6% of this breakdownFrance: 167 citing papers, 4.2% of this breakdownItaly: 162 citing papers, 4.1% of this breakdownNetherlands: 155 citing papers, 3.9% of this breakdownAustralia: 118 citing papers, 3% of this breakdownJapan: 100 citing papers, 2.5% of this breakdownBelgium: 92 citing papers, 2.3% of this breakdownChina: 69 citing papers, 1.7% of this breakdownSwitzerland: 66 citing papers, 1.6% of this breakdown
0%39.3%Other 17.5%

Fields

  • Medicine78.7%
  • Physics and Astronomy9.2%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Health Professions0.9%
  • Computer Science0.8%
  • Engineering0.5%
  • Other1.4%

Topics

  • Prostate Cancer Diagnosis and Treatment19.1%
  • Prostate Cancer Treatment and Research15.8%
  • Advanced Radiotherapy Techniques11.7%
  • Endometrial and Cervical Cancer Treatments2.8%
  • Effects of Radiation Exposure2.2%
  • Radiation Therapy and Dosimetry2.2%
  • Other46.2%

Coauthors

All papers

Open in search
  1. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2006 cited by 2,733

  2. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202

    Authors: , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2017 cited by 138

  3. Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2003 cited by 694

  4. Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2008 cited by 691

  5. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study

    Authors: , , , - International Journal of Radiation Oncology*Biology*Physics 1993 cited by 338

  6. Hypoxic regions exist in human prostate carcinoma

    Authors: , , , , , , , - Urology 1999 cited by 172

  7. DEFINITIONS OF BIOCHEMICAL FAILURE THAT BEST PREDICT CLINICAL FAILURE IN PATIENTS WITH PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION ALONE: A MULTI-INSTITUTIONAL POOLED ANALYSIS

    Authors: , , , , , , , , , , , , - The Journal of Urology 2005 cited by 141

  8. Late GI and GU complications in the treatment of prostate cancer

    Authors: , , , , , - International Journal of Radiation Oncology*Biology*Physics 1997 cited by 363

  9. Diabetes mellitus: a predictor for late radiation morbidity

    Authors: , , - International Journal of Radiation Oncology*Biology*Physics 1999 cited by 204

  10. Hypoxic prostate/muscle po2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings

    Authors: , , , , , , , - Urology 2002 cited by 188

  11. Hypoxia in Human Prostate Carcinoma

    Authors: , , , , , , , - American Journal of Clinical Oncology 2001 cited by 108

  12. COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial

    Authors: , , , , , , , , , , , - The Lancet Oncology 2007 cited by 106

  13. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma

    Authors: , , , , , - International Journal of Radiation Oncology*Biology*Physics 1993 cited by 195

  14. What Dose of External-Beam Radiation is High Enough for Prostate Cancer?

    Authors: , , , , , - International Journal of Radiation Oncology*Biology*Physics 2007 cited by 167

  15. Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy Oncology Group Trial 92–02

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2004 cited by 156

  16. Decision-making strategies for patients with localized prostate cancer

    Authors: , , , , , , , - Seminars in Urologic Oncology 2002 cited by 139

  17. Treatment Related Sequelae Following External Beam Radiation for Prostate Cancer: A Review With an Update in Patients with Stages T1 And T2 Tumor

    Authors: , , , , , , , - The Journal of Urology 1994 cited by 132

  18. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age

    Authors: , , , , , , , - Cancer 2000 cited by 131

  19. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer

    Authors: , , , , , , , - Urology 2001 cited by 76

  20. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 1997 cited by 609

  21. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

    Authors: , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1991 cited by 431

  22. The effect of dose on local control of prostate cancer

    Authors: , , - International Journal of Radiation Oncology*Biology*Physics 1988 cited by 274

  23. Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31

    Authors: , , , , , , - Journal of Clinical Oncology 2008 cited by 260

  24. Measurement of intrafractional prostate motion using magnetic resonance imaging

    Authors: , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2002 cited by 157